X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
female (31) 31
male (31) 31
aged (26) 26
middle aged (26) 26
human necessities (15) 15
hygiene (15) 15
medical or veterinary science (15) 15
double-blind method (13) 13
acute coronary syndrome (12) 12
heart attacks (12) 12
medicine, general & internal (12) 12
preparations for medical, dental, or toilet purposes (12) 12
cardiac & cardiovascular systems (11) 11
chemistry (11) 11
metallurgy (11) 11
organic chemistry (11) 11
risk factors (11) 11
specific therapeutic activity of chemical compounds ormedicinal preparations (11) 11
treatment outcome (11) 11
abridged index medicus (10) 10
care and treatment (10) 10
heterocyclic compounds (10) 10
myocardial infarction (10) 10
risk (10) 10
anticoagulants (9) 9
drug therapy, combination (9) 9
heart attack (9) 9
myocardial infarction - mortality (9) 9
acute coronary syndrome - drug therapy (8) 8
adult (8) 8
dosage and administration (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
myocardial infarction - drug therapy (8) 8
analysis (7) 7
atherosclerosis (7) 7
cardiovascular disease (7) 7
clinical trials (7) 7
coronary heart disease (7) 7
drug therapy (7) 7
electrocardiography (7) 7
myocardial-infarction (7) 7
stroke (7) 7
acute coronary syndromes (6) 6
aged, 80 and over (6) 6
hemorrhage - chemically induced (6) 6
hospitalization (6) 6
mortality (6) 6
myocardial infarction - prevention & control (6) 6
platelet aggregation inhibitors - therapeutic use (6) 6
prevention (6) 6
artery-disease (5) 5
cardiac and cardiovascular systems (5) 5
cardiology (5) 5
clinical medicine (5) 5
clopidogrel (5) 5
diabetes mellitus (5) 5
double-blind (5) 5
kardiologi (5) 5
klinisk medicin (5) 5
prospective studies (5) 5
russia (5) 5
survival analysis (5) 5
ticagrelor (5) 5
acute myocardial-infarction (4) 4
angina pectoris (4) 4
aspirin - therapeutic use (4) 4
coronary artery disease (4) 4
coronary vessels (4) 4
diabetes (4) 4
enoxaparin - therapeutic use (4) 4
fibrinolytic agents - therapeutic use (4) 4
heart failure (4) 4
heparin (4) 4
myocardial infarction - etiology (4) 4
outcomes (4) 4
peripheral vascular disease (4) 4
physics (4) 4
prognosis (4) 4
stroke - prevention & control (4) 4
therapy (4) 4
thrombolysis (4) 4
trial (4) 4
acute coronary syndrome - blood (3) 3
acute coronary syndrome - complications (3) 3
acute heart failure (3) 3
age (3) 3
alleles (3) 3
analysis of variance (3) 3
anticoagulants - therapeutic use (3) 3
antiplatelet therapy (3) 3
arteriosclerosis (3) 3
aspirin (3) 3
benzaldehydes - administration & dosage (3) 3
benzaldehydes - adverse effects (3) 3
biomarkers - blood (3) 3
cardiac patients (3) 3
cardiovascular (3) 3
cardiovascular diseases (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 8, pp. 699 - 708
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1591 - 1599
IMPORTANCE: p38 Mitogen-activated protein kinase (MAPK)–stimulated inflammation is implicated in atherogenesis, plaque destabilization, and maladaptive... 
APOPTOSIS | MEDICINE, GENERAL & INTERNAL | ACTIVATED PROTEIN-KINASE | INHIBITION | EVENTS | PATHWAY | HEART-FAILURE | MAPK | ACUTE CORONARY SYNDROME | Recurrence | Myocardial Infarction - mortality | Humans | Middle Aged | Male | Secondary Prevention | Cyclopropanes - adverse effects | Protein Kinase Inhibitors - adverse effects | Cyclopropanes - therapeutic use | Pyridines - adverse effects | Treatment Failure | Female | C-Reactive Protein - analysis | Myocardial Infarction - enzymology | Pyridines - therapeutic use | Double-Blind Method | Drug Administration Schedule | Myocardial Ischemia - prevention & control | Hospitalization | Myocardial Revascularization | Algorithms | Myocardial Infarction - drug therapy | Protein Kinase Inhibitors - therapeutic use | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Aged | Myocardial Ischemia - surgery | Clinical trials | Care and treatment | Usage | Dosage and administration | Extracellular signal-regulated kinases | Heart attack | Patient safety | Inhibitor drugs | Heart attacks | Clinical outcomes | Pyridines/adverse effects/therapeutic use | Cyclopropanes/adverse effects/therapeutic use | C-Reactive Protein/analysis | Klinisk medicin | Clinical Medicine | p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors | Myocardial Ischemia/prevention & control/surgery | Protein Kinase Inhibitors/adverse effects/therapeutic use | Myocardial Infarction/drug therapy/enzymology/mortality
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
no | TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2013, Volume 310, Issue 11, pp. 1145 - 1155
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 09/2016, Volume 134, Issue 12, pp. 861 - 871
Journal Article
American Heart Journal, ISSN 0002-8703, 2007, Volume 154, Issue 6, pp. 1078 - 1084.e1
Journal Article
European heart journal, ISSN 0195-668X, 08/2010, Volume 31, Issue 16, pp. 1993 - 2005
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 06/2009, Volume 119, Issue 22, pp. 2877 - 2885
Journal Article